Chai Discovery

Chai Discovery develops artificial intelligence models and software for protein engineering and molecular design. Its platform enables researchers to design antibodies, miniproteins, and other biomolecules from target structures or sequences while supporting different antibody formats, framework sequences, epitope selection, and molecular design criteria. The company’s technology is used to predict molecular interactions, generate de novo protein designs, and support therapeutic research by reducing experimental screening and accelerating candidate evaluation. Chai Discovery also provides controlled access to its AI models for commercial and academic research through a web-based platform.